https://doi.org/10.5281/zenodo.8136836
Mediterr J Pharm Pharm Sci, vol.3 n3, 1-8, September, 2023, Publication date July 12, 2023 Quality control of selected cosmetics marketed in Libya for traces of toxic heavy metals: urgent need of guidelines harmonization Omar A. Rbeida, Suaad M. Abuskhona, Shahrazad A. Eteer, Asma O. Jebril Cosmetics, hazards, potential heavy metal, post-marketing, Libya

Original articleQuality control

https://doi.org/10.5281/zenodo.8190815
Mediterr J Pharm Pharm Sci, vol.3 n3, 9-15, September, 2023, Publication date July 27, 2023 Effect of in-vitro differentiated bone marrow mesenchymal stem cells in the treatment of peripheral nerve injury in rats Atmaram T., Saraswathi Perumal, Balaji Karuppaiah, Saravanakumar S. Nirmal Kumar, Dhastagir S. Sheriff Bone marrow mesenchymal stem cells, electro neuro myo gram, polylactic co glycolic acid, rat

Original articlePharmacology

https://doi.org/10.5281/zenodo.8329687
Mediterr J Pharm Pharm Sci, vol.3 n3, 31-42, September, 2023, Publication date September 08, 2023 Effect of Beetroot juice supplementation on the physical and biochemical profiles of induced metabolic syndrome in rats Jeremiah Munguti, Andrew Makanya, Moses Obimbo, Vincent Kipkorir, Dennis Omondi Beetroot, cardiovascular disease, metabolic syndrome, lifestyle modification

Original articlePharmacology

Mediterr J Pharm Pharm Sci, vol.3 n3, 43-51, September, 2023, Publication date September 23, 2023 Serum electrolyte levels in Libyan patients with type II diabetes mellitus Apoajela A. Ahmed, Yousra N. Aboubaker, Hadeel A. Salh, Esraa M. Abu Alorouq, Amira M. Al Barshushi BMI, diabetes, electrolyte imbalance, glycemic control, sodium, potassium

Original articleClinical biochemistry

https://doi.org/10.5281/zenodo.8390130
Mediterr J Pharm Pharm Sci, vol.3 n3, 52-60, September, 2023, Publication date September 30, 2023 Evaluation of mineralized plasmatic matrix on augmentation of bone resorption Mohamed E.E. Abokrias, Abdulrahim M. Aldarewesh Dog, mineralized plasmatic matrix, platelet rich plasma, platelet-rich fibrin

Original articlePhysiology, Pathology

https://doi.org/10.5281/zenodo.8257097
Mediterr J Pharm Pharm Sci, vol.3 n3, 16-19, September, 2023, Publication date August 17, 2023 A toxicological study of ecballium elaterium plant in mice Galal M. Hasan, Mahmoud Kaddura, Ghazala O. Othman, Samah El-Agili, Mudafara Bengleil, Abdelhakim A.G. Ali, Awad G. Abdellatif Ecballium elaterium, LD₅₀, Libya, mouse, toxicity

Short communicationToxicology

https://doi.org/10.5281/zenodo.8262368
Mediterr J Pharm Pharm Sci, vol.3 n3, 20-26, September, 2023, Publication date August 18, 2023 Comparison between isoflurane and sevoflurane in inhalation anesthesia: a prospective study Hiba A. Alshami, Maryam S.E. Hussein, Saja J. Elmhadwi, Mabroka Z. Alfitory, Sondos K. Alfsay, Raja Abd almuneim, Ainour A.Y. Elmsmary, Nouha. E. Elshintiri Anesthesia, comparison, gases, inhalation, isoflurane, sevoflurane

Short communicationPharmacology

https://doi.org/10.5281/zenodo.8327189
Mediterr J Pharm Pharm Sci, vol.3 n3, 27-30, September, 2023, Publication date September 07, 2023 Uric acid and glucose metabolism in uncomplicated  Libyan diabetic patients   Dareen N. Shateila, Mohammed I. Aiamame, Asma I. Hamad, Ala O. Almhashhash, Raghda A. Bayou and Hiba A. Alshami Hyperinsulinemia, hyperuricemia, type 2 diabetes mellitus, uric acid

Short communicationClinical biochemistry

https://doi.org/10.5281/zenodo.8393129
Mediterr J Pharm Pharm Sci, vol.3 n3, 61-61, September, 2023, Publication date October 14, 2023 Dosing in the neonatal intensive care unit Nabila S. Hashad Clinical pharmacy, dose, intensive care unit, Libya, neonate

OpinionClinical Pharmacy